PMAM
BIIB icon

Picton Mahoney Asset Management’s Biogen BIIB Stock Holding History

Picton Mahoney Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,202
Closed -$5.19M – 433
2023
Q2 		$5.19M Buy
18,202
+959
+6% +$285K 0.22% 135
2023
Q1 		$4.79M Buy
+17,243
New +$4.77M 0.21% 147
2015
Q3 		– Sell
-77,600
Closed -$31.3M – 292
2015
Q2 		$31.3M Buy
77,600
+47,800
+160% +$19.2M 1.55% 8
2015
Q1 		$12.6M Buy
+29,800
New +$11.7M 0.48% 66
2014
Q3 		– Sell
-4,800
Closed -$1.51K – 314
2014
Q2 		$1.51K Buy
+4,800
New +$1.44M 0.09% 143

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Picton Mahoney Asset Management's BIIB Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 18,202 shares — an estimated $5.19M sold.

Picton Mahoney Asset Management first reported a position in BIIB in Q2 2014 and held it in 5 quarters. The position peaked at $31.3M in Q2 2015. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Picton Mahoney Asset Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 18,202 Biogen shares in Q3 2023, an estimated $5.19M.
  • Picton Mahoney Asset Management first reported a position in Biogen in Q2 2014 and held it in 5 quarters.
  • Picton Mahoney Asset Management's Biogen position peaked at $31.3M in Q2 2015.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.